Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Osteo Bi-Flex® Now Features Plant-Based Omega-3s to Support Whole Body Health and Wellness

Osteo Bi-Flex® is the number one pharmacist-recommended joint care supplement brand year over year. (PRNewsfoto/Osteo Bi-Flex)

News provided by

Osteo Bi-Flex

May 19, 2025, 08:03 ET

Share this article

Share toX

Share this article

Share toX

The New Osteo Bi-Flex® Advanced Omega-3 Joint Complex Helps Simplify Wellness Routines by Combining 5 Whole Body Health Benefits in Two Softgels

Osteo Bi-Flex® Launches "The Osteo Bi-Flex® Flexer Challenge" to Celebrate Product Launch and Spark More Movement

BRIDGEWATER, N.J., May 19, 2025 /PRNewswire/ -- Osteo Bi-Flex®, the number one pharmacist-recommended joint care supplement brand1 today introduced its new Osteo Bi-Flex® Advanced Omega-3 Joint Complex supplement. This new formula helps support joint and whole body health by combining 100 mg of Joint Shield 5-LOXIN Advanced®, a highly concentrated herbal extract that helps improve joint comfort within seven days† with 360 mg of omega-3s from algae oil per serving. The new Osteo Bi-Flex Advanced product features easy-to-take softgels to support five whole body health benefits, including joint health, heart health, skin health, circulation, and healthy cellular metabolism.*

Continue Reading
Osteo Bi-Flex® Advanced Omega-3 Joint Complex supplement helps support joint and whole body health by combining 100 mg of Joint Shield 5-LOXIN Advanced®, a highly concentrated herbal extract that helps improve joint comfort within seven days with 360 mg of omega-3s from algae oil per serving.
Osteo Bi-Flex® Advanced Omega-3 Joint Complex supplement helps support joint and whole body health by combining 100 mg of Joint Shield 5-LOXIN Advanced®, a highly concentrated herbal extract that helps improve joint comfort within seven days with 360 mg of omega-3s from algae oil per serving.

"We're pleased to launch our new Osteo Bi-Flex Advanced Omega-3 Joint Complex to help consumers simplify their wellness routines," said Staci Wagenbach, senior director of marketing, Osteo Bi-Flex brand. "We're combining the joint health benefits of Osteo Bi-Flex with the added health benefits of high-quality omega-3s DHA and EPA to help keep the body moving from its head to its toes and all the joints in between. By pairing Osteo Bi-Flex with omega-3s we're simplifying wellness routines, allowing consumers to pack more benefits into just two softgels per day for five whole body benefits."*

Joint Shield 5-LOXIN Advanced® is a novel composition extracted from the Boswellia serrata tree that contains high concentrations of the boswellic acid, AKBA, which helps with occasional joint flare-ups.* In previous studies, this herbal ingredient was clinically shown to improve joint comfort within seven days†, and continued to improve over time.‡*  

A study analyzed dietary intake data of over 40,000 Americans and concluded the overall intake of Omega-3 fatty acids was low. Yet, less than 8 percent of those surveyed used omega-3 supplements containing EPA and DHA.1

"The brand has been responsible for helping lead the way in the joint care supplements category for more than 25 years," continued Wagenbach. "Today, we're inviting adults to join the millions who get moving with Osteo Bi-Flex by taking our new Flexer Challenge."

Submit a video of your best dance moves for a chance to win $5,000 cash plus a year's supply of the new supplement. The entry period runs May 19 through July 19, 2025. To learn more and enter, please visit www.osteoflexerchallenge.com.**

The new Osteo Bi-Flex Advanced Omega-3 Joint Complex is available on Amazon.com and at Walmart, Kroger, Meijer and HEB. 

For more information about Osteo Bi-Flex®, please visit www.osteobiflex.com.

About Osteo Bi-Flex®

Osteo Bi-Flex® is the number one pharmacist-recommended joint care supplement brand year over year.¹ Osteo Bi-Flex features Joint Shield 5-LOXIN Advanced®, which contains high concentrations of the boswellic acid, AKBA, that helps with occasional joint flare-ups.* In studies, this herbal ingredient was clinically shown to improve joint comfort within seven days.†* For more information about Osteo Bi-Flex, please visit www.osteobiflex.com and follow @OsteoBiFlex on Facebook and @Officialosteobiflex on Instagram. To register for the Osteo Bi-Flex® Flexer Rewards program, please visit www.osteobiflex.com/pages/flexer-rewards.

†Based on three human studies with 5-LOXIN® Advanced where subjects rated their joint health over time, subjects' joint health improved within 7 days, and continued to improve throughout the duration of the studies.

¹Based on the results of the U.S. Pharmacy Times Survey of Pharmacists' OTC Recommendations who recommend a "joint health" dietary supplement, 2024-2025.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

 ‡In a select study, participants taking Joint Shield™ 5-LOXIN ADVANCED® or placebo over 90 days rated their joint comfort during daily activities. 

**NO PURCHASE NECESSARY. Starts 12:00:01 AM EST 5/19/2025, Ends 11:59:59 PM EST 7/19/2025. Three (3) Grand Prize Winners. Prize Total Approximate Retail Value of all prizes is $16,050. Visit www.osteoflexerchallenge.com for official rules. Open to legal residents of 50 US + DC, 18+. Void where prohibited.

References:
1. Cave, C. et al. Nutrients. 2020 Jul 9;12(7):2045.

Media Contact
Andrea Martin
Osteo Bi-Flex®
[email protected]

SOURCE Osteo Bi-Flex

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

New Clinical Trial Emphasizes Joint Health Benefits of Boswellia serrata Herbal Extract Featured in Osteo Bi-Flex®

New Clinical Trial Emphasizes Joint Health Benefits of Boswellia serrata Herbal Extract Featured in Osteo Bi-Flex®

A new clinical trial presented at the 2024 American Society for Nutrition Annual Meeting evaluated the effects of 100 milligrams of Boswellia serrata ...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.